secwatch.observer — SEC 8-K summary
======================================

Issuer:     UPEXI, INC. (UPXI)
CIK:        0001775194
Form:       8-K
Filed at:   2024-06-17T23:59:59+00:00
Accession:  0001477932-24-003725
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Upexi sells VitaMedica subsidiary for $6M; CEO-controlled entity part of buyer group
--------------------------------------------------------------------------------

- Sold 100% of VitaMedica to group including MFA Holdings (controlled by CEO Allan Marshall) for $6M.
- Received $4M cash at closing; $1M promissory note due in 12 months; $1M payable on 15-month anniversary.
- Transaction closed June 13, 2024 under SPA dated June 1, 2024.
- Upexi retains no ongoing interest in VitaMedica.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1775194/000147793224003725/0001477932-24-003725-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1775194/000147793224003725/upxi_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-24-003725

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer